The relative potency of lignocaine, bupivacaine and etidocaine was estimated by forearm skin weals in four volunteers. Potency was estimated as the time to half-recovery of a sharp sensation in response to a needle-prick. The increase in duration of action with increased concentration was greater for bupivacaine and etidocaine as compared with lignocaine. At the same concentrations, bupivacaine had a longer duration of action than etidocaine. However, etidocaine 1% had a longer duration of action than bupivacaine 0.5%.
The relative potency of lignocaine, bupivacaine and etidocaine was estimated by forearm skin weals in four volunteers. Potency was estimated as the time to half-recovery of a sharp sensation in response to a needle-prick. The increase in duration of action with increased concentration was greater for bupivacaine and etidocaine as compared with lignocaine. At the same concentrations, bupivacaine had a longer duration of action than etidocaine. However, etidocaine 1% had a longer duration of action than bupivacaine 0.5%.
The assessment of any new local anaesthetic agent must include investigations into its potency, its latency (time to onset of action) and its toxicity, both local and general. In such assessments it is important to determine the activity of the new drug in relation to a standard. In 1957, Bonica discussed the various methods which may be used to test these properties, the difficulty of extrapolating from animal studies to man and the problems of testing new agents in the clinical situation. Probably the least variation occurs when using intradermal weals, and this technique has been used to compare local anaesthetic activity in both animals (Biilbring and Wajda, 1945) and man (Sinha, 1936; Geddes, 1956 ). The technique also gives information on the duration of action and local toxicity.
If potency is defined as the reciprocal of the concentration required to achieve a specific effect to a specific end-point, then one form of potency, probably the most important for local anaesthesia, relates to the duration of action. Potency, in terms of duration, is then defined by the concentration of local anaesthetic which produces analgesia for a given time. Relative potency is thus the inverse ratio of two of these concentrations.
This study was designed to compare the potency of the new local anaesthetic agent etidocaine with lignocaine, which we have regarded as the standard, and bupivacaine. 1.0%. Sodium chloride 0.9% in water (normal saline) was included as a control. No solution contained adrenaline. The lower concentrations of each drug were made by dilution of the highest concentration with saline in a 1-ml graduated syringe. Each test weal was made by injecting 0.2 ml of the test solution intradermally with a 25-gauge needle. Care was taken to ensure that there was no leakage of fluid. The outline of each weal was marked accurately with ink, and numbered.
Site of weals. On the flexor surface of the forearm, a line was drawn from the medial side of the biceps tendon to the palmaris longus tendon at the wrist. Any watch-band area was avoided. Weals were raised on alternate sides of this line 2 cm apart. In this way it was possible to make eight weals on each forearm. The order of the test solutions and the saline control used to make the weals down the forearm was determined from an 8x8 latin square. Neither the subject nor the investigator knew the identity of the weals and the subject could not see which weal was being tested.
Testing. Sensation was tested with a Down's No. 10 fine triangular straight needle. The needle was weighted with circular lead weights about its shaft 15 mm from the tip. Before raising the weals, the number of weights was adjusted for each individual so that every needle-prick was felt as being sharp along the whole length of the forearm. The actual sites of the weals were not used during this preliminary testing. The needle was applied through a guide so that the weights alone pressed the needle against the skin ( fig. 1 ). Using this method, we found that the needle did not penetrate the skin, and yet there was sufficient pressure to give the subject a sensation of a sharp prick.
Each weal was tested four times, at 5-min inter-R=l-(C/K)=(l-e-" 1 )-Return of sensation was regarded as being the return of a pricking feeling when the stimulus was applied. However, return of sensation occurred gradually, so that four stimuli to a single weal resulted in the perception of 1, 2, 3 or 4 pricks. The progressive increase in the number of pricks perceived was taken to be an estimate of the degree of recovery of sensation.
The sum of the positive prick responses at each 5-min interval for each concentration of each drug for the eight experimental situations was derived.
FIG. 1. Diagram of pricking device. The weighted needle is applied to the forearm until the whole weight is on the needle point. Each marked weal is tested four times in a selected pattern. The test pattern is varied so that the whole test area is evenly pricked.
vals. The order of testing was determined from a table of random numbers. This number defined the first weal to be tested. Each alternate weal was tested, then the remaining weals in sequence. Thus if weal number 3 was tested first, the order would be 3, 5, 7, 1, 2, 4, 6, 8, while if number 6 was first tested the order would be 6, 8, 2, 4, 5, 7, 1, 3. When the needle was applied to anaesthetized skin, either no sensation or one of light touch was felt. The end-point was the return of a sharp pricking sensation, which could not always be appreciated accurately when sensation was recovering. The number of sharp pricks felt on each test was recorded. The procedure was continued until four sharp pricks were recorded for all weals on the same test, or until 240 min had elapsed since injection, with four pricks recorded for all weals at least once.
Subjects. The subjects were four adult male volunteers from the Department of Anaesthetics at the Hammersmith Hospital. The right and left arms were used on separate occasions, so that, in all, eight complete experiments were performed.
Statistical method.
If recovery is assumed to be a simple washout of the drug from the tissues, the concentration (Q of the drug in the tissues declines in the form C=Ke-ot ; where t=time and a and K are constants for the conditions. If one further assumes a uniform distribution of nerve sensitivity, then the block of the nerve will have the same form. Thus the recovery (R) will be the residual, that is, The maximum possible value for each point of time was therefore 32. Values from 6% (2/32) to the first value over 65% (21/32) were used to estimate a best fit line of the theoretical form outlined above ( fig. 2 ). Where necessary, data were taken above 65 % recovery, so that at least 10 data points were used for the estimate of each curve (table I) . The curves were estimated from the equation:
where y is the degree of recovery and T is the delay time to the beginning of return of sensation. This equation was estimated by a least-squares linear regression. A half-recovery time (y=0.5, 16/32) was estimated from the fitted line as a measure of the duration of action of the anaesthetic agent. An estimate of the variability of T was not made as this would require extrapolation. The variability of Armitage (1971) , where y is the mean observed value of y.)
RESULTS
Sensation was present in the normal saline weal on the first test (zero time) and recovery was usually complete within the first 10 min, so that pressure or mechanical damage to the tissues had little part to play in the remaining results (table I) . The duration of effect of the local anaesthetic solutions differed considerably between individuals. The fastest time for recovery of sensation in all weals was 85 min, and the longest was 240 min. Each subject, however, showed similar durations of effect on each arm. Table II shows the estimated time for the beginning of return of sensation, the rate of return of sensation and the correlation coefficient for the data for each drug. Figure 3 shows the time for 50% recovery for each concentration of the different agents. If potency is defined by duration of action, then bupivacaine is more potent than etidocaine, which in turn is more potent than lignocaine. The similar slopes of the concentration/duration lines for bupi- vacaine and etidocaine suggest that the removal of these drugs from a skin weal follows a similar pattern. During these experiments, stinging was a common experience with all test solutions. No weals showed any evidence of an inflammatory, allergic or toxic reaction during testing or the following day. None of the drugs caused any general reaction in any subject.
DISCUSSION
Skin weals in humans have been used to test local anaesthetic activity by Sinha (1936) and Geddes (1956) . In this study we attempted to apply a standard stimulus to the skin. Initial testing showed a considerable difference in individual sensitivity to pinprick. Thus the pricking pressure was adjusted by adding weights to the needle until the subject consistently perceived the stimulus as a sharp prick sensation at all points on the forearm. The difficulty in perceiving the sensation as a sharp prick may be related to the sparse innervation of the flexor surface of the forearm. This would be consistent with our own observations that two-point discrimination in this area was 1 cm or greater whereas on a finger it is usually about 3 mm.
From the results obtained, it can be seen that increasing the concentration of lignocaine did not markedly prolong its duration of action as compared with the findings for etidocaine and bupivacaine. The difference in slope of the concentration/duration lines between lignocaine and the other drugs is probably a reflection of the difference in removal of the agents from the skin weaL This is in keeping with animal studies (Adams, Kronberg and Takman, 1972) and is compatible with the known differences in protein binding of the drugs; lignocaine is bound much less than either etidocaine or bupivacaine (Tucker et al., 1970; Lund, Cwik and Pagdanganan, 1973) .
These results illustrate the difficulty in estimating relative potency. Because the slopes for lignocaine and etidocaine differ ( fig. 3) , the drugs are equipotent at a concentration of 0.25%, but lignocaine 1% corresponds with an estimated 0.32%, giving 31 min analgesia; thus etidocaine is three times more potent than lignocaine. However, the dose/ response lines for bupivacaine and etidocaine are parallel, so that in general bupivacaine can be said to be 1.5 times more potent than etidocaine. This illustrates that one of the important assumptions underlying potency ratios is that the dose/response curves are parallel. Thus single doses of drugs should never be used for comparisons of this type.
At a concentration of 0.5%, therefore, bupivacaine has a longer duration of action than etido-caine. However, it would appear that etidocainc can be used safely in a concentration of 1%, a strength at which bupivacaine is not used because of its systemic toxitity, and a longer duration of effect could be expected with etidocaine 1%. The work of Scott, Jebson and Boyes (1973) suggests that the systemic toxicity of etidocaine may be less than that of bupivacaine. They showed that etidocaine disappeared much more quickly from the plasma than bupivacaine, with plasma concentrations which were 40-50% lower at all times, and that it was distributed in a much larger volume in the body. These workers stressed that further work is required before any definite conclusions can be drawn about the relative systemic toxidty of the two drugs. Animal experiments also suggest that subcutaneous etidocaine is less toxic than bupivacaine (Adams, Kronberg and Takman, 1972) .
We have heard recently that bupivacaine 0.75% has been used in clinical practice, in the United States, apparently without any toxic reaction. We have no experience of this concentration but, from extrapolation of the bupivacaine line in figure 3 , we would expect the duration of action of bupivacaine 0.75% to be closely comparable to that of etidocaine 1%. This agrees with Lund and colleagues (1973) .
This study gives no information about some very important clinical aspects of local anaesthetic pharmacology, such as tissue penetrability and latency of onset, and the results apply only to skin weals. In other sites, the removal of the local anaesthetic agent may occur in ways which are totally different, and governed by factors other than those which apply to skin weals.
CONCLUSION
Etidocaine would appear to be a satisfactory local anaesthetic agent. It has a duration of action less than an equal concentration of bupivacaine but greater than lignocaine at 1%, when tested by skin weals. The change in duration of action with change in concentration parallels that of bupivacaine. This similarity suggests a similar pattern of clearance for etidocaine and bupivacaine from skin weals. The duration of analgesia, as measured by a half-recovery time, which is obtainable with bupivacaine 0.5% is less than the duration of analgesia obtained by etidocaine 1%.
RESUME
On a estim6 l'efficacite' relative de la lignocaine, de la bupivacaine et dc l'e'tidocaine en se basant sur des papules produites sur la peau de l'avant-bras chez quatre volontaires. L'efficaati a itt eValuee comme dtant le temps jusqu'a demi-rdtablissement d'une sensation soudaine faisant suite a une piqure d'aiguille. L augmentation de la durfc de l'action en fonction de la concentration accrue est supe'rieure dans le cas de la bupivacaine et de l'eudocaine par comparaison a lignocaine. A concentrations egaks, la bupivacaine avait unc durfc d'action plus longue que l'etidocaine. Toutefois, l'itidocaine a 1% avait une duree d'action plus longue que la bupivacaine 4 0,5*. de la acci6n con concentration aumentada fue mayor para la bupivacaina y eddocaina comparadas con la lignorafna. SUMAHIO Con las misTTin^ concentraciones, la bupivacaina tuyo una Se C3tim6 la potencia relative de lignocalna, bupivacaina y mayor durati6n en su acci6n que la eddocaina. Sin emeddocaina por mediation de las senates en la piel del ante-bargo, la eddocaina al 1 % tuvo una mayor duration de brazo de 4 voluntarios. Se estim6 la potencia como el tiem-acti6n que la bupivacaina al 0,5%.
